SCHEMBL5844995

SCHEMBL5844995

O=C(COC(O)(C(=O)c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.45
L3MBTL1 Q9Y468 4/20 0.44
TDP1 Q9NUW8 3/20 0.44
MAPT P10636 3/20 0.42
HPGD P15428 2/20 0.42
MAPK1 P28482 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
KMT2A Q03164 1/20 0.42
SRC P12931 1/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
GSK3B P49841 2/20 0.40
PTPN1 P18031 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL251616 0.81 CES1 (0.50) CES1MAPTSMN1; SMN2MEN1CYP3A4
SCHEMBL12003255 0.81 CES1 (0.46) CES1TDP1MAPTHPGDMAPK1
SCHEMBL5844751 0.80 KMT2A (0.47) CES1L3MBTL1TDP1MAPK1MEN1
SCHEMBL9192066 0.79 CES1 (0.47) CES1L3MBTL1TDP1MAPTMAPK1
SCHEMBL11101775 0.78 CES1 (0.53) CES1L3MBTL1TDP1MAPTHPGD
SCHEMBL2814678 0.78 CES1 (0.46) CES1MAPTHPGDSRCRAB9A
Ether SCHEMBL6049600 0.78 CES1 (0.46) CES1MAPTSMN1; SMN2MEN1CYP3A4
SCHEMBL948686 0.78 CES1 (0.50) CES1TDP1HPGDSMN1; SMN2KDM4E
SCHEMBL621110 0.77 CES1 (0.52) CES1L3MBTL1TDP1MAPTMAPK1
SCHEMBL2819529 0.76 CES1 (0.45) CES1L3MBTL1TDP1MAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6984645-B2 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein BRISTOL-MYERS SQUIBB COMPANY (US) 2006-01-10 US disclosed